Gulf Stream faces near-term funding risk with 0.1 quarters of cash

Zydeco-1 drilling leaves Gulf Stream with 0.1 quarters of funding

Gulf Stream Energy Limited (ASX:GSE), formerly Galilee Energy, finished the September quarter with A$234,000 in cash after burning A$2.893 million on operating activities. On the figures reported to ASX, that equates to an estimated 0.1 quarters of funding, with no unused finance facilities available at quarter end.

The company said the cash drain was driven by significant expenditure on the spudding and drilling of the Zydeco-1 well, which was completed during the quarter. That explanation matters because the reported cash runway is based on a period containing an unusually large exploration outlay, rather than a stated expectation that the same spending rate will continue.

Capital raising has started, but the terms are not disclosed

Gulf Stream said it does not expect to maintain the current level of net operating cash flow because the Zydeco-1 drilling program has been completed. It also said capital-raising activities commenced during the quarter and that it is working with corporate advisers to monitor cash levels, expenditure commitments and funding opportunities.

The filing does not state how much the company intends to raise, whether the funding will be secured through an equity issue or another structure, or when it might be completed. Its statement that it has a track record of raising funds as required is management’s explanation for why it expects to continue operating, not a disclosed financing commitment.

Zydeco-1 now carries both funding pressure and technical questions

The cash pressure arrives as the company works to advance the same well that recently produced oil indications in two zones. Those earlier results were based on logs and had not yet been flow-tested, while the company later assigned contingent resources and prepared a workover plan for one of the zones in its Zydeco oil-zone results. The filing does not provide new drilling results or confirm commercial production.

Operating payments included A$2.675 million for exploration and evaluation, A$76,000 in staff costs and A$178,000 in administration and corporate costs. The company also reported A$1.401 million of payments to related parties, described in a footnote as executive director, non-executive director and company secretarial fees.

Quarter-end cash was partly replenished by equity funding

Financing activities provided a net A$930,000 during the quarter. This comprised A$935,000 from equity securities, less A$62,000 of transaction costs and A$57,000 classified as other financing proceeds. Even with that inflow, cash fell from A$2.198 million at the start of the period to A$234,000 at quarter end, after the operating deficit and a small A$1,000 foreign-exchange effect.

The next financial test is therefore not simply whether Zydeco-1 spending has subsided. It is whether the capital raising now under way can be completed before the remaining cash is consumed, and on terms that provide enough room for the company’s next operational step.